Ukko is a biotechnology company dedicated to designing safe immunotherapies to rapidly treat allergies and other immune-mediated conditions. Our proprietary technology platform has the potential to reduce or eliminate potentially dangerous allergic reactions, while inducing a protective immune response. By rethinking how to prevent allergic reactions at the molecular level, we aim to develop a safer, more precise alternative to traditional allergy desensitization methods, starting with individuals at risk for life-threatening allergic reactions to peanut.
| Website | https://www.ukko.us |
| Revenue | $9.1 million |
| Employees | 58 (24 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+9 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Food and Beverage, Health Care |
| Keywords | Allergy Solutions, Food Allergies, Allergy Treatment, Allergy Management, Immunology Research, Biomedical Research, Computational Biology, Immunotherapy, Cutting Edge Technology, Plant Science, Food Science, Biotechnology, Novel Therapies, Drug Development, Scientific Research, Personalized Medicine, Precision Medicine, Health Technology, Clinical Research |
| Competitors | Hiscox USA, Zywave, Next Insurance, CoverHound, Policygenius Inc., CoverWallet, an Aon company, Verisk Financial, Embroker, Thimble, Insureon +38 more (view full list) |
Looking for a particular Ukko employee's phone or email?
Ukko Questions
The Ukko annual revenue was $9.1 million in 2026.
Matt Ottmer is the COO of Ukko.
24 people are employed at Ukko.
Ukko is based in Boston, Massachusetts.
Top Ukko Employees
-
Matt Ottmer
Chief Operating Officer at Ukko
Boston, MA, US25 -
Uri Lopatin
CEO at Ukko
San Francisco, CA, US5+5+ -
Joanna Tyrekidis
CEO at Ukko
Liège, WAL, BE25 -
Timothy Soos
Vice President Translational Medicine at Ukko
Boston, MA, US25+ -
Judith Weiss Paltiel
Site Manager at Ukko
Mazkeret Batya, Center District, IL1
